US Patent 9630931 Pharmaceutically active pyrazine derivatives
Patent 9630931 was granted and assigned to Sentinel Oncology Limited on April, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9630931 Pharmaceutically active pyrazine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.